“Molecular Docking Study of Gingkgo Biloba Compounds As Potential Inhibitors of SARS-CoV-2”. SCRIPTA SCORE Scientific Medical Journal 4, no. 1 (September 1, 2022): 30–43. Accessed February 4, 2026. https://idjpcr.usu.ac.id/scripta/article/view/8399.